Crossref journal-article
Elsevier BV
Trends in Cell Biology (78)
Bibliography

Rechsteiner, M., & Hill, C. P. (2005). Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends in Cell Biology, 15(1), 27–33.

Authors 2
  1. Martin Rechsteiner (first)
  2. Christopher P. Hill (additional)
References 64 Referenced 318
  1. 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q / Bioessays / Ubiquitin-mediated proteolysis: biological regulation via destruction by Ciechanover (2000)
  2. 10.1126/science.7725097 / Science / Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4Å resolution by Löwe (1995)
  3. 10.1038/386463a0 / Nature / Structure of 20S proteasome from yeast at 2.4Å resolution by Groll (1997)
  4. 10.1038/80992 / Nat. Struct. Biol. / A gated channel into the proteasome core particle by Groll (2000)
  5. 10.1146/annurev.biochem.68.1.1015 / Annu. Rev. Biochem. / The 26S proteasome: a molecular machine designed for controlled proteolysis by Voges (1999)
  6. {'key': '10.1016/j.tcb.2004.11.003_bib6', 'first-page': '73', 'article-title': 'The 11S regulators of 20S proteasome activity', 'volume': '268', 'author': 'Hill', 'year': '2002', 'journal-title': 'Curr. Top. Microbiol. Immunol.'} / Curr. Top. Microbiol. Immunol. / The 11S regulators of 20S proteasome activity by Hill (2002)
  7. 10.1093/emboj/cdf333 / EMBO J. / PA200, a nuclear proteasome activator involved in DNA repair by Ustrell (2002)
  8. 10.1038/35040607 / Nature / Structural basis for the activation of 20S proteasomes by 11S regulators by Whitby (2000)
  9. 10.1093/emboj/cdg436 / EMBO J. / The pore of activated 20S proteasomes has an ordered 7-fold symmetric conformation by Forster (2003)
  10. 10.1093/emboj/20.13.3359 / EMBO J. / Lysine 188 substitutions convert the pattern of proteasome activation by REGγ to that of REGs α and β by Li (2001)
  11. 10.1074/jbc.275.19.14336 / J. Biol. Chem. / Hybrid proteasomes. Induction by interferon-γ and contribution to ATP-dependent proteolysis by Tanahashi (2000)
  12. 10.1016/j.jsb.2004.01.013 / J. Struct. Biol. / New HEAT-like repeat motifs in proteins regulating proteasome structure and function by Kajava (2004)
  13. 10.1074/jbc.M007379200 / J. Biol. Chem. / Identification and characterization of a Drosophila nuclear proteasome regulator. A homolog of human 11 S REGγ (PA28γ) by Masson (2001)
  14. 10.4049/jimmunol.167.12.6859 / J. Immunol. / Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver by Khan (2001)
  15. 10.1038/ni1088 / Nat. Immunol. / The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules by Watts (2004)
  16. 10.1038/nri1250 / Nat. Rev. Immunol. / Making sense of mass destruction: quantitating MHC class I antigen presentation by Yewdell (2003)
  17. 10.1042/bj3450001 / Biochem. J. / The proteasome activator 11 S REG (PA28) and class I antigen presentation by Rechsteiner (2000)
  18. 10.1126/science.286.5447.2162 / Science / Impaired immunoproteasome assembly and immune responses in PA28−/− mice by Preckel (1999)
  19. 10.1093/emboj/20.21.5898 / EMBO J. / Immunoproteasome assembly and antigen presentation in mice lacking both PA28α and PA28β by Murata (2001)
  20. 10.1002/1521-4141(200012)30:12<3672::AID-IMMU3672>3.0.CO;2-B / Eur. J. Immunol. / The proteasome regulator PA28α/β can enhance antigen presentation without affecting 20S proteasome subunit composition by Schwarz (2000)
  21. 10.1093/intimm/13.12.1515 / Int. Immunol. / Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation by Li (2001)
  22. 10.1084/jem.20011922 / J. Exp. Med. / Two distinct pathways mediated by PA28 and hsp90 in major histocompatibility complex class I antigen processing by Yamano (2002)
  23. 10.1074/jbc.274.6.3363 / J. Biol. Chem. / The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation by Kisselev (1999)
  24. 10.1093/emboj/21.11.2636 / EMBO J. / Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes by Cascio (2002)
  25. 10.1152/jappl.2000.88.3.1134 / J. Appl. Physiol. / Chronic contractile activity upregulates the proteasome system in rabbit skeletal muscle by Ordway (2000)
  26. 10.1042/bj20030282 / Biochem. J. / Changes in the proteolytic activities of proteasomes and lysosomes in human fibroblasts produced by serum withdrawal, amino-acid deprivation and confluent conditions by Fuertes (2003)
  27. 10.1074/mcp.M200051-MCP200 / Mol. Cell. Proteomics / Protein profiling of the human epidermis from the elderly reveals up-regulation of a signature of interferon-{γ}-induced polypeptides that includes manganese-superoxide dismutase and the p85{β} subunit of phosphatidylinositol 3-kinase by Gromov (2003)
  28. 10.1074/jbc.275.12.9055 / J. Biol. Chem. / A critical role for the proteasome activator PA28 in the Hsp90-dependent protein refolding by Minami (2000)
  29. 10.1074/jbc.274.53.38211 / J. Biol. Chem. / Growth retardation in mice lacking the proteasome activator PA28γ by Murata (1999)
  30. 10.4049/jimmunol.172.6.3948 / J. Immunol. / Immune defects in 28-kDa proteasome activator γ-deficient mice by Barton (2004)
  31. 10.1016/S0022-2836(03)00188-8 / J. Mol. Biol. / Drosophila proteasome regulator REGγ: transcriptional activation by DNA replication-related factor DREF and evidence for a role in cell cycle progression by Masson (2003)
  32. 10.1016/0014-4827(89)90299-1 / Exp. Cell Res. / Loss in transformed cells of cell cycle regulation of expression of a nuclear protein recognized by SLE patient antisera by Nikaido (1989)
  33. 10.1042/bj20021758 / Biochem. J. / MEKK3 interacts with the PA28 γ regulatory subunit of the proteasome by Hagemann (2003)
  34. 10.1016/S0092-8674(00)00116-1 / Cell / Signal transduction by the JNK group of MAP kinases by Davis (2000)
  35. 10.1038/19709 / Nature / The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis by Imai (1999)
  36. 10.1016/S0092-8674(00)80294-9 / Cell / Daxx, a novel Fas-binding protein that activates JNK and apoptosis by Yang (1997)
  37. 10.1128/MCB.23.20.7108-7121.2003 / Mol. Cell. Biol. / Daxx silencing sensitizes cells to multiple apoptotic pathways by Chen (2003)
  38. 10.1016/j.bbrc.2003.08.033 / Biochem. Biophys. Res. Commun. / RanBPM is a novel binding protein for p75NTR by Bai (2003)
  39. 10.1074/jbc.M101085200 / J. Biol. Chem. / Induction of apoptosis by protein inhibitor of activated Stat1 through c-Jun NH2-terminal kinase activation by Liu (2001)
  40. 10.1210/jc.2002-021413 / J. Clin. Endocrinol. Metab. / Abnormally high expression of proteasome activator-γ in thyroid neoplasm by Okamura (2003)
  41. 10.1038/ncb1003-845 / Nat. Cell Biol. / Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation by Lipford (2003)
  42. 10.1124/mol.65.3.761 / Mol. Pharmacol. / DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells – toward a basis for the opposite actions elicited by two nuclear receptors? by Obradovic (2004)
  43. 10.1128/JVI.77.19.10237-10249.2003 / J. Virol. / Proteasome activator PA28γ-dependent nuclear retention and degradation of hepatitis C virus core protein by Moriishi (2003)
  44. 10.1158/0008-5472.CAN-03-2729 / Cancer Res. / A genome-wide screen in Saccharomyces cerevisiae reveals altered transport as a mechanism of resistance to the anticancer drug bleomycin by Aouida (2004)
  45. 10.1038/sj.embor.embor938 / EMBO Rep. / Blm3 is part of nascent proteasomes and is involved in a late stage of nuclear proteasome assembly by Fehlker (2003)
  46. 10.1096/fj.03-0610com / FASEB J. / Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression by Lecker (2004)
  47. 10.1038/nrc1361 / Nat. Rev. Cancer / The proteasome: a suitable antineoplastic target by Adams (2004)
  48. 10.1006/abbi.2000.1870 / Arch. Biochem. Biophys. / CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90 by Goasduff (2000)
  49. 10.1006/abbi.2001.2270 / Arch. Biochem. Biophys. / Heat shock protein-90 and the catalytic activities of the 20 S proteasome (multicatalytic proteinase complex) by Lu (2001)
  50. 10.1074/jbc.M001697200 / J. Biol. Chem. / cDNA cloning, expression, and functional characterization of PI31, a proline-rich inhibitor of the proteasome by McCutchen-Maloney (2000)
  51. 10.1073/pnas.212257299 / Proc. Natl. Acad. Sci. U. S. A. / PI31 is a modulator of proteasome formation and antigen processing by Zaiss (2002)
  52. 10.1016/S0014-5793(99)01072-8 / FEBS Lett. / The proteasome inhibitor PI31 competes with PA28 for binding to 20S proteasomes by Zaiss (1999)
  53. 10.1073/pnas.91.23.11035 / Proc. Natl. Acad. Sci. U. S. A. / Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds by Gallo (1994)
  54. 10.1172/JCI9826 / J. Clin. Invest. / Inhibition of ubiquitin–proteasome pathway-mediated IκBα degradation by a naturally occurring antibacterial peptide by Gao (2000)
  55. 10.1038/71527 / Nat. Med. / PR39, a peptide regulator of angiogenesis by Li (2000)
  56. 10.1021/bi034784f / Biochemistry / Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activity by Gaczynska (2003)
  57. 10.1126/science.2194290 / Science / A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator by Nelbock (1990)
  58. 10.1074/jbc.272.13.8145 / J. Biol. Chem. / HIV-1 tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation by Seeger (1997)
  59. 10.1016/S0022-2836(02)00998-1 / J. Mol. Biol. / The RTP site shared by the HIV-1 Tat protein and the 11S regulator subunit α is crucial for their effects on proteasome function including antigen processing by Huang (2002)
  60. 10.1016/S0014-5793(03)01025-1 / FEBS Lett. / Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal α and β subunits by Apcher (2003)
  61. 10.1128/JVI.73.9.7231-7240.1999 / J. Virol. / Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex by Hu (1999)
  62. 10.1128/jvi.70.8.5582-5591.1996 / J. Virol. / Proteasome complex as a potential cellular target of hepatitis B virus X protein by Huang (1996)
  63. 10.1515/BC.2003.005 / Biol. Chem. / Hepatitis B virus HBx peptide 116–138 and proteasome activator PA28 compete for binding to the proteasome α4/MC6 subunit by Stohwasser (2003)
  64. 10.1016/S0969-2126(02)00748-7 / Structure / The structure of the mammalian 20S proteasome at 2.75Å resolution by Unno (2002)
Dates
Type When
Created 20 years, 8 months ago (Dec. 16, 2004, 8:07 a.m.)
Deposited 1 year, 3 months ago (May 6, 2024, 4:49 p.m.)
Indexed 5 days, 11 hours ago (Aug. 21, 2025, 2:24 p.m.)
Issued 20 years, 7 months ago (Jan. 1, 2005)
Published 20 years, 7 months ago (Jan. 1, 2005)
Published Print 20 years, 7 months ago (Jan. 1, 2005)
Funders 0

None

@article{Rechsteiner_2005, title={Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors}, volume={15}, ISSN={0962-8924}, url={http://dx.doi.org/10.1016/j.tcb.2004.11.003}, DOI={10.1016/j.tcb.2004.11.003}, number={1}, journal={Trends in Cell Biology}, publisher={Elsevier BV}, author={Rechsteiner, Martin and Hill, Christopher P.}, year={2005}, month=jan, pages={27–33} }